NVIV

InVivo Therapeutics Holdings Corp
NVIV

Overview Fund Activity
Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

51 hedge funds and large institutions have $6.42M invested in InVivo Therapeutics Holdings Corp in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 8 closing their positions.

Holders
51
Holders Change
+1
Holders Change %
+2%
% of All Funds
1.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
9
Reduced
18
Closed
8
Calls
–
Puts
$25K
Net Calls
-$25K
Net Calls Change
+$81K

Top Buyers

1
ICM
1
IMS Capital Management
Oregon
$731K
2
ARTA
2
A.R.T. Advisors
New York
$78K
3
WS
3
Wedbush Securities
California
$73K
4
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
$69K
5
RJA
5
Raymond James & Associates
Florida
$126K

Top Sellers

1
Legal & General Group
1
Legal & General Group
United Kingdom
$0
2
State Street
2
State Street
Massachusetts
$34K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$0
4
ECM
4
Element Capital Management
New York
$0
5
PP
5
Paloma Partners
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
PP
51
Paloma Partners
Connecticut
– – -83,400 Closed
William Blair & Company
52
William Blair & Company
Illinois
– – -58,800 Closed
LP
53
LMR Partners
United Kingdom
– – -58,775 Closed
Deutsche Bank
54
Deutsche Bank
Germany
$0 81 -41,457 -100%
HighTower Advisors
55
HighTower Advisors
Illinois
– – -21,125 Closed
Creative Planning
56
Creative Planning
Kansas
– – -4,163 Closed
PNC Financial Services Group
57
PNC Financial Services Group
Pennsylvania
$0 250 – –
PCA
58
Peddock Capital Advisors
Massachusetts
$0 53 – –
Simplex Trading
59
Simplex Trading
Illinois
$0 330 +330 New
1 2
3